186 related articles for article (PubMed ID: 38032290)
1. The ferroptosis landscape in acute myeloid leukemia.
Ma Z; Ye W; Huang X; Li X; Li F; Lin X; Hu C; Wang J; Jin J; Zhu B; Huang J
Aging (Albany NY); 2023 Nov; 15(22):13486-13503. PubMed ID: 38032290
[TBL] [Abstract][Full Text] [Related]
2. Prognostic and Immunological Role of Key Genes of Ferroptosis in Pan-Cancer.
Shi ZZ; Tao H; Fan ZW; Song SJ; Bai J
Front Cell Dev Biol; 2021; 9():748925. PubMed ID: 34722530
[TBL] [Abstract][Full Text] [Related]
3. Targeting BMAL1 reverses drug resistance of acute myeloid leukemia cells and promotes ferroptosis through HMGB1-GPX4 signaling pathway.
Zheng H; Wu T; Lin Z; Wang D; Zhang J; Zeng T; Liu L; Shen J; Zhao M; Li JD; Yang M
J Cancer Res Clin Oncol; 2024 May; 150(5):231. PubMed ID: 38703241
[TBL] [Abstract][Full Text] [Related]
4. Ferroptosis model system by the re-expression of BACH1.
Irikura R; Nishizawa H; Nakajima K; Yamanaka M; Chen G; Tanaka K; Onodera M; Matsumoto M; Igarashi K
J Biochem; 2023 Jul; 174(3):239-252. PubMed ID: 37094356
[TBL] [Abstract][Full Text] [Related]
5. Resveratrol drives ferroptosis of acute myeloid leukemia cells through Hsa-miR-335-5p/NFS1/ GPX4 pathway in a ROS-dependent manner.
Liu J; Gao W; Sheng Y; Sun J; Wen D
Cell Mol Biol (Noisy-le-grand); 2023 Jul; 69(7):131-137. PubMed ID: 37715395
[TBL] [Abstract][Full Text] [Related]
6. HIVEP3 cooperates with ferroptosis gene signatures to confer adverse prognosis in acute myeloid leukemia.
Zhang X; Zhang X; Liu K; Li W; Wang J; Liu P; Ma W
Cancer Med; 2022 Dec; 11(24):5050-5065. PubMed ID: 35535739
[TBL] [Abstract][Full Text] [Related]
7. Predictive and prognostic impact of ferroptosis-related genes ACSL4 and GPX4 on breast cancer treated with neoadjuvant chemotherapy.
Sha R; Xu Y; Yuan C; Sheng X; Wu Z; Peng J; Wang Y; Lin Y; Zhou L; Xu S; Zhang J; Yin W; Lu J
EBioMedicine; 2021 Sep; 71():103560. PubMed ID: 34482070
[TBL] [Abstract][Full Text] [Related]
8. The Role of the
Chen SL; Qin ZY; Hu F; Wang Y; Dai YJ; Liang Y
Genes (Basel); 2019 Aug; 10(8):. PubMed ID: 31426381
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive analysis of ferroptosis-related gene signatures as a potential therapeutic target for acute myeloid leukemia: A bioinformatics analysis and experimental verification.
Zheng Z; Hong X; Huang X; Jiang X; Jiang H; Huang Y; Wu W; Xue Y; Lin D
Front Oncol; 2022; 12():930654. PubMed ID: 36033479
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of tumor propellant glutathione peroxidase 4 induces ferroptosis in cancer cells and enhances anticancer effect of cisplatin.
Zhang X; Sui S; Wang L; Li H; Zhang L; Xu S; Zheng X
J Cell Physiol; 2020 Apr; 235(4):3425-3437. PubMed ID: 31556117
[TBL] [Abstract][Full Text] [Related]
11. The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis.
Bersuker K; Hendricks JM; Li Z; Magtanong L; Ford B; Tang PH; Roberts MA; Tong B; Maimone TJ; Zoncu R; Bassik MC; Nomura DK; Dixon SJ; Olzmann JA
Nature; 2019 Nov; 575(7784):688-692. PubMed ID: 31634900
[TBL] [Abstract][Full Text] [Related]
12. Targeting NRF2 uncovered an intrinsic susceptibility of acute myeloid leukemia cells to ferroptosis.
Liu X; Zhong S; Qiu K; Chen X; Wu W; Zheng J; Liu Y; Wu H; Fan S; Nie D; Wang X; Yu Z; Liao Z; Zhong M; Li Y; Zeng C
Exp Hematol Oncol; 2023 May; 12(1):47. PubMed ID: 37198609
[TBL] [Abstract][Full Text] [Related]
13. FSP1 is a glutathione-independent ferroptosis suppressor.
Doll S; Freitas FP; Shah R; Aldrovandi M; da Silva MC; Ingold I; Goya Grocin A; Xavier da Silva TN; Panzilius E; Scheel CH; Mourão A; Buday K; Sato M; Wanninger J; Vignane T; Mohana V; Rehberg M; Flatley A; Schepers A; Kurz A; White D; Sauer M; Sattler M; Tate EW; Schmitz W; Schulze A; O'Donnell V; Proneth B; Popowicz GM; Pratt DA; Angeli JPF; Conrad M
Nature; 2019 Nov; 575(7784):693-698. PubMed ID: 31634899
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of ferroptosis defense enzyme Gpx4 retards motor neuron disease of SOD1G93A mice.
Chen L; Na R; Danae McLane K; Thompson CS; Gao J; Wang X; Ran Q
Sci Rep; 2021 Jun; 11(1):12890. PubMed ID: 34145375
[TBL] [Abstract][Full Text] [Related]
15. MiR-15a-3p regulates ferroptosis via targeting glutathione peroxidase GPX4 in colorectal cancer.
Liu L; Yao H; Zhou X; Chen J; Chen G; Shi X; Wu G; Zhou G; He S
Mol Carcinog; 2022 Mar; 61(3):301-310. PubMed ID: 34727409
[TBL] [Abstract][Full Text] [Related]
16. Protein phosphatase 2A-B55β mediated mitochondrial p-GPX4 dephosphorylation promoted sorafenib-induced ferroptosis in hepatocellular carcinoma via regulating p53 retrograde signaling.
Qian B; Che L; Du ZB; Guo NJ; Wu XM; Yang L; Zheng ZX; Gao YL; Wang MZ; Chen XX; Xu L; Zhou ZJ; Lin YC; Lin ZN
Theranostics; 2023; 13(12):4288-4302. PubMed ID: 37554285
[No Abstract] [Full Text] [Related]
17. STYK1/NOK correlates with ferroptosis in non-small cell lung carcinoma.
Lai Y; Zhang Z; Li J; Li W; Huang Z; Zhang C; Li X; Zhao J
Biochem Biophys Res Commun; 2019 Nov; 519(4):659-666. PubMed ID: 31542233
[TBL] [Abstract][Full Text] [Related]
18. A Novel Identified Circular RNA, mmu_mmu_circRNA_0000309, Involves in Germacrone-Mediated Improvement of Diabetic Nephropathy Through Regulating Ferroptosis by Targeting miR-188-3p/GPX4 Signaling Axis.
Jin J; Wang Y; Zheng D; Liang M; He Q
Antioxid Redox Signal; 2022 Apr; 36(10-12):740-759. PubMed ID: 34913724
[No Abstract] [Full Text] [Related]
19. Increased expression of GPX4 promotes the tumorigenesis of thyroid cancer by inhibiting ferroptosis and predicts poor clinical outcomes.
Chen H; Peng F; Xu J; Wang G; Zhao Y
Aging (Albany NY); 2023 Jan; 15(1):230-245. PubMed ID: 36626251
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of ferroptosis-related genes and their methylation in AML.
Zhou F; Chen B
Hematology; 2021 Dec; 26(1):919-930. PubMed ID: 34789073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
